Heron Therapeutics (HRTX) Net Cash Flow (QoQ) (2010 - 2026)

Heron Therapeutics (HRTX) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Heron Therapeutics 85.57 Mn 55.60 Mn 24.07 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 82.46%
Dec 31, 2025 -154.31%
Sep 30, 2025 1,064.48%
Jun 30, 2025 57.86%
Mar 31, 2025 -10,809.84%
Dec 31, 2024 -99.17%
Sep 30, 2024 456.35%
Jun 30, 2024 74.91%
Mar 31, 2024 -33.08%
Dec 31, 2023 -128.89%
Sep 30, 2023 257.01%
Jun 30, 2023 -216.22%
Mar 31, 2023 133.43%
Dec 31, 2022 -2,017.66%
Sep 30, 2022 122.03%
Jun 30, 2022 75.31%
Mar 31, 2022 51.28%
Dec 31, 2021 -118.43%
Sep 30, 2021 -124.04%
Jun 30, 2021 389.51%